Effect of Bothrops alternatus snake venom on macrophage phagocytosis and superoxide production: Participation of protein kinase C

Journal of Venomous Animals and Toxins Including Tropical Diseases

Volumn 17, Issue 4, 2011, Pages 430-441

  Setubal, S S ^a   Pontes, A S ^a   Furtado, J L ^a   Kayano, A M ^a   Stabeli R G ^a,b   Zuliani, J P ^a,b  

^a INSTITUTO OSWALDO CRUZ   (Brazil)

^b Center of Biomolecules Applied to Medicine   (Brazil)

Author keywords

Bothrops; Inflammation; Macrophages; Phagocytosis; Protein kinase C; Snake venom; Superoxide

Indexed keywords

COMPLEMENT RECEPTOR; PROTEIN KINASE C; REACTIVE OXYGEN METABOLITE; SNAKE VENOM; SUPEROXIDE; THIOGLYCOLIC ACID; ZYMOSAN;

ANIMAL CELL; ARTICLE; BOTHROPS ALTERNATUS; CELL ADHESION; CONCENTRATION RESPONSE; CONTROLLED STUDY; MACROPHAGE ACTIVATION; NONHUMAN; OPSONIZATION; PERITONEUM MACROPHAGE; PHAGOCYTOSIS; SIGNAL TRANSDUCTION;

EID: 83255185635     PISSN: 16789180     EISSN: 16789199     Source Type: Journal    
DOI: None     Document Type: Article

References (80)

1. Oliveira RC, Wen FH, Sifuentes DN. Epidemiologia dos acidentes por animais peçonhentos. In: Cardoso JL, Haddad-Jr V, França FOS, Wen FH, Malaque CMS, editors. Animais peçonhentos do Brasil: biologia, clínica e terapêutica. 2nd ed. São Paulo: Sarvier; 2009. p. 6-21.
2. Brasil. Ministério da Saúde. Manual de diagnóstico e tratamento de acidentes por animais peçonhentos. 2nd ed. Brasília: Fundação Nacional de Saúde; 2008.
3. Amorim MF, Franco de Mello, R, Saliba F. Envenenamento botrópico e crotálico. Mem Inst Butantan. 1951;23:108.
4. Barraviera B. Acidentes por serpentes do gênero Crotalus. Arq Bras Med. 1990;64:14-20.
5. Barraviera B. Estudo clínico dos acidentes ofídicos. J Bras Med. 1993;65(4):209-50.
6. Campbell JA, Lamar WW. The venomous reptiles of Latin America. Cornell Univ. Press: Ithaca; 1989. p. 425.
7. Fenwick AM, Gutberlet RL Jr, Evans JA, Christopher LP. Morphological and molecular evidence for phylogeny and classification of South American pitvipers, genera Bothrops, Bothriopsis, and Bothrocophias (Serpentes: Viperidae). Zool J Linn Soc. 2009;156(3):617-40.
8. Rosenfeld G. Symptomatology, pathology and treatment of snakes bites in South America. In: Burchel, W, Buckley, EE, editors. Venomous animals and their venoms. New York: Academic Press; 1971. p. 345-403.
9. Furtado MF, Maruyama M, Kamiguti AS, Antonio LC. Comparative study of nine Bothrops snake venoms from adult female snakes and their offspring. Toxicon. 1991;29(2):219-26.
10. de Roodt AR, Dolab JA, Galarce PP, Gould E, Litwin S, Dokmetjian JC, et al. A study on the venom yield of venomous snake species from Argentina. Toxicon. 1998;36(12):1949-57
11. Mebs D. A comparative study of enzyme activities in snake venoms. Int J Biochem. 1970;1(3):335-42.
12. Tan NH, Ponnudurai G. A comparative study of the biological properties of some venoms of snacks of the genus Bothrops (American lance-headed viper). Comp Biochem Physiol. 1991;100(2):361-5.
13. Stábeli RG, Marcussi S, Carlos GB, Pietro RC, Selistre-de-Araújo HS, Giglio JR, et al. Platelet aggregation and antibacterial effects of an L-amino acid oxidase purified from Brothops alternatus snake venom. Bioorg Med Chem. 2004;12(11):2881-6.
14. Nisenbom HE, Seki C, Vidal JC. Phospholipase A2 from Bothrops alternatus (víbora de la cruz) venom. Purification and some characteristic properties. Toxicon. 1986;24(3):259-72.
15. Smolka MB, Marangoni S, Oliveira B, Novello JC. Purification and partial characterization of a thrombin-like enzyme, balterobin, from the venom of Bothrops alternatus. Toxicon. 1998;36(7):1059-63.
16. Castro HC, Dutra DL, Oliveira-Carvalho AL, Zingali RB. Bothroalternin, a thrombin inhibitor from the venom of Bothrops alternatus. Toxicon. 1998;36(12):1903-12.
17. Souza DH, Iemma MR, Ferreira LL, Faria JP, Oliva ML, Zingali RB, et AL. The disintegrin-like domain of the snake venom metalloprotease alternagin inhibits alpha2beta1 integrin-mediated cell adhesion. Arch Biochem Biophys. 2000;384(2):341-50.
18. Mariano-Oliveira A, Coelho AL, Terruggi CH, Selistre-de-Araújo HS, Barja-Fidalgo C, De Freitas MS. Alternagin-C, a nonRGD-disintegrin, induces neutrophil migration via integrin signaling. Eur J Biochem. 2003;270(24):4799-808.
19. Cominetti MR, Ribeiro JU, Fox JW, Selistre-de-Araujo, HS. BaG, a new dimeric metalloproteinase/disintegrin from the Bothrops alternatus snake venom, that interacts with alpha5beta1 integrin. Arch Biochem Biophys. 2003;416(2):171-9.
20. Cominetti MR, Terrugi CHB, Ramos OHP, Fox JW, Figueiredo CC, Mariano-Oliveira A, et al. Alternagin-C, a disintegrin like protein, induces vascular endothelial cell growth factor (VEGF) expression and endothelial cell proliferation in vitro. J Biol Chem. 2004;279(18):18247-55.
21. Gay CC, Leiva IC, Maruñak S, Teibler P, Acosta de Pérez O. Proteolytic, edematogenic and myotoxic activities of a hemorrhagic metalloproteinase isolated from Bothrops alternatus venom. Toxicon. 2005;46(5):546-54.
22. Selistre-de-Araújo HS, Cominetti MR, Terruggi CH, Mariano-Oliveira A, De Freitas MS, Crepin M, et al. Alternagin-C, a disintegrin-like protein from the venom of Bothrops alternatus, modulates alpha2beta1 integrin-mediated cell adhesion, migration and proliferation. Braz J Med Biol Res. 2005;38(10):1505-11.
23. Valério AA, Corradini AC, Panunto PC, Mello SM, Hyslop S. Purification and characterization of a phosphodiesterase from Bothrops alternatus snake venom. J Protein Chem. 2002;21(8):495-503.
24. Bauab FA, Junqueira GR, Corradini MC, Silveira PV, Nishioka S de A. Clinical and epidemiological aspects of the 'urutu' lance-headed viper (Bothrops alternatus) bite in a Brazilian hospital. Trop Med Parasitol. 1994;45(3):243-5.
25. Maruñak SL, Acosta De Pérez O, Ruíz De Torrent RM, Teibler GP. Hemorrhagic, edema-forming, proteolytic and myonecrotic activities of viper venoms of Bothrops alternatus (Vibora de la Cruz). Acta Physiol Pharmacol Ther Latinoam. 1999;49(3):149-54.
26. de Roodt AR, Dolab JA, Dokmetjian JC, Litwin S, Segre L, Vidal JCA. A comparison of different methods to assess the hemorrhagic activity of Bothrops venoms. Toxicon. 2000;38(6):865-73.
27. Queiroz LS, Santo-Neto H, Rodrigues-Simioni L, Prado-Franceschi J. Muscle necrosis regeneration after envenomation by Bothrops jararacussu snake venom. Toxicon. 1984;22(3):339-46.
28. Sanchez EF, Freitas TV, Ferreira-Alves DL, Velarde DT, Diniz MR, Cordeiro MN. Biological activities of venoms from South American snakes. Toxicon. 1992;30(1):95-103.
29. Gutiérrez JM, Ownby CL, Odell GV. Skeletal muscle regeneration after myonecrosis induced by crude venom and a myotoxin from the snake Bothrops asper (Fer-de-Lance). Toxicon. 1984;22(5):719-31
30. Gutiérrez JM, Chaves F, Cerdas L. Inflammatory infiltrate in skeletal muscle injected with Bothrops asper venom. Rev Biol Trop. 1986;34(2):209-19.
31. Trebien HA, Calixto JB. Pharmacological evaluation of rat paw oedema induced by Bothrops jararaca venom. Agents Actions.1989;26(3-4):292-300.
32. Flores CA, Zappellini A, Prado-Franceschi J. Lypoxygenase-derived mediators may be involved in in vivo neutrophil migration induced by Bothrops erythromelas and Bothrops alternatus venom. Toxicon. 1993;31(12):1551-9.
33. Zamuner SR, Gutiérrez JM, Muscará MN, Teixeira SA, Teixeira CF. Bothrops asper and Bothrops jararaca snake venoms trigger microbicidal functions of peritoneal leukocytes in vivo. Toxicon.2001;39(10):1505-13.
34. Acosta de Pérez O, Teibler P, Koscinczuk P, Sánchez Negrette M, Trulls H, Maruñak S. Edema and myonecrosis induced by Bothrops jararaca venom of Argentina in mice. Acta Physiol Pharmacol Ther Latinoam. 1996;46(4):233-8.
35. Farsky SH, Walber J, Costa-Cruz JW, Cury Y, Teixeira CF. Leukocyte response induced by Bothrops jararaca crude venom. In vivo and in vitro studies. Toxicon. 1997;35(2):185-93.
36. Naito M. Macrophage heterogeneity in development and differentiation. Arch Histol Cytol. 1993;56(4):331-51.
37. Aderem A, Underhill DM. Mechanisms of phagocytosis in macrophages. Annu Rev Immunol. 1999;17:593-23.
38. Brown GD, Gordon S. Immune recognition. A new receptor for beta-glucans. Nature. 2001; 413: 36-7.
39. Brown WJ, Chambers K, Doody A. Phospholipase A2 (PLA2) enzymes in membrane trafficking: mediators of membrane shape and function. Traffic. 2003;4(4):214-21.
40. Herre J, Gordon S, Brown GD. Dectin-1 and its role in the recognition of beta-glucans by macrophages. Mol Immunol. 2004;40(12):869-76.
41. Herre J, Marshall AS, Caron E, Edwards AD, Williams DL, Schweighoffer E, et al. Dectin-1 uses novel mechanisms for yeast phagocytosis in macrophages. Blood. 2004;104(13):4038-45.
42. Wright SD, Silverstein SC. Tumor-promoting phorbol esters stimulate C3b and C3b' receptor-mediated phagocytosis in cultured human monocytes. J Exp Med. 1982;156(4):1149-64.
43. Griffin FM Jr, Mullinax PJ. Effects of differentiation in vivo and of lymphokine treatment in vitro on the mobility of C3 receptors of human and mouse mononuclear phagocytes. J Immunol. 1985;135(5):3394-7.
44. Ross GD, Vetvicka V. CR3 (CD11b, CD18): a phagocyte and NK cell membrane receptor with multiple ligand specificities and functions. Clin Exp Immunol. 1993;92(2):181-4.
45. Williams MA, Solomkin JS. Integrin-mediated signaling in human neutrophil functioning. J Leukoc Biol. 1999;65(6):725-36.
46. Schmidt A, Caron E, Hall A. Lipopolysaccharide-induced activation of beta2-integrin function in macrophages requires Irak kinase activity, p38 mitogen-activated protein kinase, and the Rap1 GTPase. Mol Cell Biol. 2001;21(2):438-48.
47. Caron E. Cellular functions of the Rap 1 GTP-binding protein: a pattern emerges. J Cell Sci. 2003;116(Pt 3)435-40.
48. Lim J, Wiedemann A, Tzircotis G, Monkley SJ, Critchley DR, Caron E. An essential role for talin during alpha(M)beta(2)-mediated phagocytosis. Mol Biol Cell. 2007;18(3):976-85.
49. Wright SD, Griffin FM Jr. Activation of phagocytic cells' C3 receptors for phagocytosis. J Leukoc Biol. 1985;38(2):327-39.
50. Van Kooyk Y, Figdor CG. Avidity regulation of integrins: the driving force in leukocyte adhesion. Curr Opin Cell Biol. 2000;12(5):542-7.
51. Babior BM. NADPH oxidase: an update. Blood. 1999;93(4):1464-76.
52. Babior BM. NADPH oxidase. Curr Opin Immunol. 2004;16(1):42-7.
53. Babior BM, Lambeth, JD, Nauseef W. The neutrophil NADPH oxidase. Arch Biochem Biophys. 2002;397(2):342-4.
54. Forman HJ, Torres M. Reactive oxygen species and cell signaling: Respiratory burst in macrophage signaling. Am J Respir Crit Care Med. 2002;166(12 Pt 2):S4-8.
55. Zuliani JP, Gutiérrez JM, Casais e Silva LL, Sampaio SC, Teixeira CFP. Activation of cellular functions in macrophages by venom secretory Asp-49 and Lys-49 Phospholipases A2. Toxicon. 2005;46(3):523-32.
56. Rosen H, Gordon S. Monoclonal antibody to the murine type 3 complement receptor inhibits adhesion of myelomonocytic cells in vitro and anflamatory cell recruitment in vivo. J Exp Med. 1987;166:1685-701.
57. Costa Rosa LF, Safi DA, Curi R. Effect of thioglycollate and BCG stimuli on glucose and glutamine metabolism in rat macrophages. J Leukoc Biol. 1994; 56(1):10-4.
58. Madhavi N, Das VN. Effects os n-6 and n-3 fatty acids on the survival of vincristine sensitive and resistant human cervical carcinoma cells, in vitro. Cancer Lett. 1994;84(1):31-41.
59. Oliveira JC, de Oca HM, Duarte MM, Diniz CR, Fortes-Dias CL. Toxicity of South American snake venoms measured by an in vitro cell culture assay. Toxicon. 2002. 40(3):321-5.
60. Moreira V, Gutiérrez JM, Amaral RB, Zamunér SR, Teixeira C de F. Effects of Bothrops asper snake venom on the expression of cyclooxygenases and production of prostaglandins by peritoneal leukocytes in vivo, and by isolated neutrophils and macrophages in vitro. Prostaglandins Leukot Essent Fatty Acids. 2009. 80(2-3):107-14.
61. Taylor AC. Attachment and spreading of cells in culture. Exp Cell Res. 1961; 8:154-73.
62. Robertson TA, Maley MA, Grounds MD, Papadimitriou JM. The role of macrophages in skeletal muscle regeneration with particular reference to chemotaxis. Exp Cell Res. 1993;207(2):321-31.
63. Ohno S, Nishizuka Y. Protein kinase C isotypes and their specific functions: prologue. J Biochem. 2002;132(4):509-11.
64. Allen LA, Aderem A. Molecular definition of distinct cytoesqueletal structures involved in complement-and Fc receptor-mediated phagocytosis in macrophages. J Exp Med. 1996;184(2):627-37.
65. Larsen EC, Di Gennaro JA, Saito N, Metha S, Loegering, DJ, Mazurkiewicz JM, et al. Differential requirement for classic and novel PKC isoforms in respiratory burst and phagocytosis in RAW 264.7 cells. J Immunol. 2000;165(5):2809-17.
66. Yedovitzky M, Mochly-Rosen D, Johnson JA, Gray MO, Ron D, Abramovitchi E, et al. Translocation inhibitors define specificity of PKC isoenzymes in pancreatic β cells. J Biol Chem. 1997;272(3):1417-20.
67. Nishizuka Y. Protein kinase C and lipid signaling for sustained cellular responses. FASEB J. 1995;9(7):484-96.
68. Kashiwagi K, Shirai Y, Kuriyama M, Sakai N, Saito N. Importance of C1B domain for lipid messenger-induced targeting of protein kinase C. J Biol Chem. 2002;277(20):18037-45.
69. Newton AC. Protein Kinase C: structural and spatial regulation by phosphorilatyon, cofactors, and macromolecular interactions. Chem Rev. 2001;101(8):2353-64.
70. Newton AC. Regulation of the ABC kinases by phosphorylation: protein kinase C as a paradigm. Biochem J. 2003;370(Pt 2):361-71.
71. Babior BM, Kipnes RS, Curcnutte JT. Biological defense mechanism. The production by leukocytes of superoxide, a potential bactericidal agent. J Clin Invest.1973;52(3):741-4.
72. El-Benna J, Dang PM, Gougerot-Pocidalo MA, Elbim C. Phagocyte NADPH oxidase: a multicomponent enzyme essential for host defenses. Arch Immunol Ther Exp (Warsz). 2005;53(3):199-206.
73. Meischl C, Roos D. The molecular basis of chronic granulomatous disease. Springer Semin Immunopathol. 1998;19(4):417-34.
74. Kannengiesser C, Gérard B, El Benna J, Henri D, Kroviarski Y, Chollet-Martin S, et al. Molecular epidemiology of chronic granulomatous disease in a series of 80 kindreds: identification of 31 novel mutations. Hum Mutat. 2008;29(9):132-49.
75. Vignais PV. The superoxide-generating NADPH oxidase: structural aspects and activation mechanism. Cell Mol Life Sci. 2002;59(9):1428-59.
76. Groemping Y, Rittinger K. Activation and assembly of the NADPH-oxidase: a structural perspective. Biochem J. 2005;386(Pt 3):401-16.
77. el Benna J, Faust LP, Babior BM. The phosphorylation of the respiratory burst oxidase component p47phox during neutrophil activation. Phosphorylation of sites recognized by protein kinase C and by proline directed kinases. J Biol Chem.1994;269(38):23431-6.
78. Faust LR, el Benna J, Babior BM., Chanock SJ. The phosphorylation targets of p47phox, a subunit of the respiratory burst oxidase. Functions of the individual target serines as evaluated by site-directed mutagenesis. J Clin Invest. 1995;96(3):1499-505.
79. Quinn MT, Gauss KA. Structure and regulation of the neutrophil respiratory burst oxidase: comparison with nonphagocyte oxidases. J Leukoc Biol. 2004;76(4):760-81.
80. Fay AJ, Qian X, Jan YN, Jan LY. SK channels mediate NADPH oxidase-independent reactive oxygen species production and apoptosis in granulocytes. Proc Natl Acad Sci USA. 2006; 103(46):17548-53.